AUROPHARMA is Making Symmetrical Triangle Pattern (Breakout)
Aurobindo Pharma Limited: Pharmaceutical Company (
AUROPHARMA) is Making Symmetrical Triangle Pattern (PATTERN BREAKOUT TRADE).
This can become a very good trade for iNTRADAY Traders.
Target + StopLoss: There is no target here. You keep the first target as much as the StopLoss you put. And the StopLoss will be the Low/High of the candle that BROKE this pattern. Or Low/High swing backward inside the pattern.
And as soon as you get a profit of 0.70% of your TARGET, you will trail your StopLoss and bring it to the entry point. And as soon as your first target is hit, you will release half of your total quantity and continue to trail your StopLoss above the last swing Low/High.
Target and StopLoss are never already FiXED in the chart pattern.
You always have to trade only by Money Management, Position Sizing, StopLoss Trailing. This is the way to stay in PROFiT.
If you want to get something good like this EVERYDAY then follow me here on TradingView now.
Chart Published By Ravinder Sharma
Thank U.
AUROPHARMA) is Making Symmetrical Triangle Pattern (PATTERN BREAKOUT TRADE).This can become a very good trade for iNTRADAY Traders.
Target + StopLoss: There is no target here. You keep the first target as much as the StopLoss you put. And the StopLoss will be the Low/High of the candle that BROKE this pattern. Or Low/High swing backward inside the pattern.
And as soon as you get a profit of 0.70% of your TARGET, you will trail your StopLoss and bring it to the entry point. And as soon as your first target is hit, you will release half of your total quantity and continue to trail your StopLoss above the last swing Low/High.
Target and StopLoss are never already FiXED in the chart pattern.
You always have to trade only by Money Management, Position Sizing, StopLoss Trailing. This is the way to stay in PROFiT.
If you want to get something good like this EVERYDAY then follow me here on TradingView now.
Chart Published By Ravinder Sharma
Thank U.
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。